May 24, 2024

unic power

health life

‘Biotechnology, synthetic biology and precision fermentation are radically transforming food’

4 min read

Ingredient supplier Kerry Taste & Nutrition has acquired a majority stake in c-LEcta, a biotech company specialising in enzyme engineering and bioprocess development.

The German biotech group will continue to operate on a stand-alone basis and existing management will remain in post and retain a stake in the business. “This decision is to ensure that the c-LEcta team remains completely focused on innovation, research and commercialisation of their specialist technologies, while also providing Kerry access to their capabilities and platforms,”​ Kerry’s head of science and technology Albert McQuaid told FoodNavigator.

Expanding Kerry’s biotech expertise

Through the deal, Kerry is building a ‘strategic partnership’ with this ‘highly innovative biotech company’ that, McQuaid observed, benefits from ‘leadership positions in enzyme engineering, fermentation and bioprocess development’.

c-LEcta is a fully integrated biotech group covering a large part of the value chain, from discovery, to engineering and commercial production of enzymes. Located in Leipzig, the group works in the realisation of high-value biotechnology products for regulated markets, either as in-house development or in close cooperation with the industry.

C-LEcta innovation capability delivers ‘cost-efficient and sustainable production processes’, creating growth opportunities across existing and new markets. “They research and develop fermentation-based products, including disruptive new enzymes and other technologies, which are used to create better, more sustainable and healthier products,”​ McQuaid elaborated.

Copyright © All rights reserved. | Newsphere by AF themes.